Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAPNNASDAQ:EURKNASDAQ:LATGNASDAQ:RAIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPNCayson Acquisition$10.28$10.22$9.95▼$10.47$80.49MN/A24,610 shs12 shsEURKEureka Acquisition$10.38$10.37$10.03▼$10.41$79.37MN/A61,838 shs727 shsLATGChenghe Acquisition I$11.90+40.0%$11.90$6.50▼$14.99$80.68M0.0771,415 shs16,389 shsRAINRain Oncology$3.71-2.0%$1.21$0.82▼$11.32$20.53M-0.1132,376 shs8,471 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPNCayson Acquisition0.00%-0.39%+0.39%+1.38%+1,027,999,900.00%EURKEureka Acquisition+0.14%0.00%-0.05%+1.17%+1,038,999,900.00%LATGChenghe Acquisition I0.00%0.00%0.00%0.00%+4.85%RAINRain Oncology+3.28%+35.00%-45.22%+77.46%+212.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPNCayson AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AEURKEureka AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ALATGChenghe Acquisition IN/AN/AN/AN/AN/AN/AN/AN/ARAINRain OncologyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPNCayson Acquisition 0.00N/AN/AN/AEURKEureka Acquisition 0.00N/AN/AN/ALATGChenghe Acquisition I 0.00N/AN/AN/ARAINRain Oncology 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPNCayson AcquisitionN/AN/AN/AN/AN/AN/AEURKEureka AcquisitionN/AN/AN/AN/AN/AN/ALATGChenghe Acquisition IN/AN/A$0.22 per share53.78($0.70) per shareN/ARAINRain OncologyN/AN/A$0.50 per share7.41($0.69) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPNCayson AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AEURKEureka AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALATGChenghe Acquisition I$430K-$0.35N/A∞N/AN/AN/A-8.81%N/ARAINRain Oncology$3.10MN/A0.00∞N/AN/AN/A-9.51%N/ALatest RAIN, LATG, CAPN, and EURK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025RAINRain OncologyN/A-$0.20N/A-$0.20N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPNCayson AcquisitionN/AN/AN/AN/AN/AEURKEureka AcquisitionN/AN/AN/AN/AN/ALATGChenghe Acquisition IN/AN/AN/AN/AN/ARAINRain OncologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPNCayson AcquisitionN/AN/AN/AEURKEureka AcquisitionN/AN/AN/ALATGChenghe Acquisition IN/A0.010.01RAINRain OncologyN/A0.010.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPNCayson AcquisitionN/AEURKEureka AcquisitionN/ALATGChenghe Acquisition I50.85%RAINRain Oncology25.79%Insider OwnershipCompanyInsider OwnershipCAPNCayson Acquisition69.75%EURKEureka Acquisition21.78%LATGChenghe Acquisition I54.63%RAINRain Oncology17.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPNCayson AcquisitionN/A7.83 million2.37 millionN/AEURKEureka AcquisitionN/A7.65 millionN/AN/ALATGChenghe Acquisition IN/A6.78 million3.08 millionNot OptionableRAINRain Oncology635.54 million4.57 millionNo DataRAIN, LATG, CAPN, and EURK HeadlinesRecent News About These CompaniesRiders brave the rain to ride for a cause during Cruise for CancerJune 9 at 5:04 AM | msn.com'AI Can Detect Cancer, But Bengaluru Still Can’t Handle Rain?' Investor's Viral Rant Sparks DebateMay 21, 2025 | msn.comThousands brave rainy weather for Race For Hope to fund brain cancer researchMay 9, 2025 | msn.comPart of Horn Island is up for sale, listed for $25MMay 9, 2025 | wlox.com10-year-old cancer survivor rings bell, throws first pitch at Space Cowboys gameMay 3, 2025 | msn.comLead singer for popular U.K. rock band dies at 66May 1, 2025 | msn.comMike Peters Dies: The Alarm’s Frontman Was 66May 1, 2025 | msn.comThey Can’t Rain on Her ParadeApril 14, 2025 | capemaycountyherald.comToronto runners brave rain to raise roughly $23,000 for cancer fightMarch 15, 2025 | msn.com13-year-old rain cancer survivor calls out Democrats: ‘Stop being mean to Trump’March 8, 2025 | msn.comBrain cancer: Recognising tumour symptoms, risk factors and seeking treatmentNovember 24, 2024 | msn.comStars shine despite rain on Illinois’ Night of ChampionsNovember 15, 2024 | harnessracingupdate.comUI researcher wins $10 million dollars to combat ovarian cancerNovember 14, 2024 | kwwl.com'Smart freeway' to cut commute for thousands of Perth motoristsNovember 14, 2024 | 9news.com.auIcy spots possible Wednesday morning as temperatures fall below freezingNovember 13, 2024 | atlantic.ctvnews.caNewfoundland man electrocuted by downed power line, two women injuredNovember 11, 2024 | msn.comKing Charles III and Kate attend remembrance events as both slowly return to dutyNovember 11, 2024 | msn.comPrince William describes family's ‘brutal’ year as wife and father faced cancer treatmentNovember 8, 2024 | msn.comThe Eras Tour kept me going during my breast cancer treatmentNovember 8, 2024 | theglobeandmail.comSheila Jackson Lee’s daughter to finish her mother’s term before former Houston mayor takes 18th Congressional DistrictNovember 7, 2024 | click2houston.comMedia Sentiment Over TimeRAIN, LATG, CAPN, and EURK Company DescriptionsCayson Acquisition NASDAQ:CAPN$10.28 0.00 (0.00%) As of 06/11/2025Cayson Acquisition Corp is a blank check company. It formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Cayson Acquisition Corp is based in NEW YORK.Eureka Acquisition NASDAQ:EURK$10.38 0.00 (0.00%) Closing price 03:59 AM EasternExtended Trading$10.38 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eureka Acquisition Corp focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in Grand Cayman, the Cayman Islands.Chenghe Acquisition I NASDAQ:LATG$11.90 +3.40 (+40.00%) Closing price 01/15/2025Extended Trading$11.40 -0.50 (-4.16%) As of 01/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chenghe Acquisition I Co. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus search for an initial business combination in the TMT, green energy, biotechnology, optoelectronics, and other sectors in the Asia Pacific. The company was formerly known as LatAmGrowth SPAC and changed its name to Chenghe Acquisition I Co. in November 2023. Chenghe Acquisition I Co. was incorporated in 2021 and is based in Singapore.Rain Oncology NASDAQ:RAINAs of January 26, 2024, operates as a subsidiary of Pathos AI, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ignore the Noise—Samsara Stock Is Still a Strong Buy Oracle’s Cloud Boom Is Just Getting Started Netflix Sets New Highs—Price Targets Keep Climbing IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA Alibaba’s Dip Is a Gift—Here’s the Price That Matters Betting on Disruption: Is Lemonade the Future of Insurance? Starbucks Stock: Culture Fix May Be Key to Long-Term Growth GameStop Turns a Profit, But Core Business Keeps Shrinking Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
